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Repair of complex cardiac lesions has been facilitated by the 
availability 01 valved conduits to reertablirh right ventricular lo 
pubttonaq artery continuity. From IDi: to June 1791, t4g 
patleob uoderws: repair *itb insertion of a conduit. Their me** 
age was 6.6 )Iean ,I, days to 45 yaw. The diagnoris \YIE 
transposition of the great arteries with ventricular eptal defect 
and left vettMcul~r oulRaw tract obstruction in 51, tr~ntus 
arteriosur io 36, pulmonary atnsia with wntrieular septal defect 
In 25, tetral~ of Fatlot in 19, douhte-outlet right ventricle in 10, 
pubnottary strnia with intact ventricular septum in 6 and *trio. 
ventricular canal with pulmonary 3trfdis in 1. 
A Dacr~, porclncvslvrd conduit was used in 37. a homograit 
mnduit in 106 and a nonvalved conduit in 5. There were 13 early 
deaths ovcral, .s.g?&,; * (226, oftlIe oarty dPathS wcurred ill the 
37 pstients wsho recekd a Dacron graft. 4,3.8%, occurred in the 
The use of extracardiac conduits has greatly advanced the 
surgical management of many types of congenital heart 
defects. The extracardiac onduit is most frequently used to 
establish continuity between the right ventricle and the 
pulmonary artery as part of the anatomic repair in many 
conditions. These include pulmonary atresia. lrlralogy of 
Fallot with either severe outflow trac1 obstructton or anon+ 
alous origin of the lefl anterior descending coronary artery, 
tmncus arteriosus and complex forms of transposition of the 
great arteries (l-7). Physiologic repair is now possible for 
many of these congenital defects. With a reduction in early 
mortality, attention has turned to the long-term outcome in 
patients with such repair, particularly the long-term function 
of the varietv of valved conduits used. 
Review dr late results from many centers (8-17) reveals 
the development of conduit obstruction and valve failure 
requirmg reoperation in a significant number of patients 
(IO?? to So%b at 5 years). Long-term patency has varied in the 
many types of conduits and valves tried. With development 
of techniques of cryopresewation, the homoetaft has been 
reintroduced and advocated as a superior conduit with 
improved long-term funclion over that of a porcine-valved 
conduit. In this report we review our expetience with the 
surgical repair of c&otruncal abnomtalities with rhe use of a 
valved conduit. The c6ectiven.a of this iomt of surgical 
management. as well as the long-term outcome of the 
various conduits. is discussed. 
Methods 
Patient profile. From 1977 to June 1991, 148 patients 
underwent repair of complex congenital cardiac lesions with 
the use of a valved or nonvalved conduit from the right 
ventricle to the pulmonary artery. Because the physiology 
and anatomy of lesions requiting a Fontan procedure aad the 
resullam Row dynamics are different, patients wdh a Fontan 
repair were not included in rhts series. The diagnoses in- 
cluded transwsition of the great arteries with ventricular 
septal defect-and left ventricular outflow tract obstruction in 
51 patients. truncus arteriosus in 36. pulmonary atresia with 
ventrw~lar septal defect in 25, complex forms of tetrology of 
Fallr,t in 19. dcuble-co:lrt rtght ~enfnclc in 10. puimonsry 
atresia vi!k izixc~ venlrw~lar septum in 6 and an atrioves- 
tricular (AV) canal in 1 pat&!. The mean age was 6.6 years 
(range ! i dzy; to 45 years). Twenty-nine patienls were <I 
year old at the time of operation: 62 patients were male and 
86 female. Twenty-one operations wre rcopcrations for a 
failed conduit. 
A Dacron porcine-valved conduit was used in 37 pntientr. 
a homograft condut in 106 and a nonvalved coadui! n 5. The 
nonvalved condoits ,nciuJed iw: nonvalved Dacron con- 
*,_,:.; ^ ^” periatiis! t,dv am nv.) Gcre-Ten condaits. T!r 
average homogwff six waa I J mm (I I fo 25 mm, and the 
average Dacron conduit tize was 17 5 mm (I2 to 25 mm). Of 
the homografts used, 84 were .?“rtir and 22 were pulmonary. 
Glotaraldekyde-treated pericardium (n = 19) or, more re- 
cently, albumin-impregnated Dacron (n = 65) was used for 
proximal augmentation. 
Patient selection. F‘aients requning valved conduit ploce- 
ment were selected according I” established criteria. Pulmo- 
nary vaxular resistance, ventricular function and pulmo- 
nary artery rmatomy were key factors in determining suitable 
operative candidates and in planning the operawe approach. 
The decision regarding conduit type and size was made at 
the time of operation by the attending surgeon on the basis of 
patient age and sue. spcco?c lesion and conduit availability. 
In the more recent cases homqraft conduita with Dacron 
augmentation were used preferentially. inclusion in the 
study was voluntary and follow-up was kept confidential. 
Surgical technique. Patients were placed on cardiopulmo- 
nary bypass with hicaval cannulakon IDLP). A ief: vcnlric- 
ular vent (DLP) war placed through the right superior 
pulmonary vein in moot cases. After cooling to 24”C, the 
heart was arrested with warm, substrate-enriched blood 
cardioplegic solution followed by a multidose cold blood 
cardioplegic solution. Marc recently cardioplegic solution 
was delivered retrograde through the c”ronary sinus. partic- 
ularly when aortic or tronchl valve regurgitation WRS 
present. Topical hypothermis was also employed. 
A vcntriculotomy was made in the right ventncular 
outflow tract (Fig. IA) and the ventricular seplai defect, 
whe!i present. was closed either primarily or with a Dacron 
patch (Fig. IB). Pulmonary xtety reconstruction was per- 
formed when necessary with “se of pericardium, homograft 
or polytctrafluoroethylene. The distal conduit anaatomosis 
was performed first with a running polypropylene sotore 
reinforced with a pericardial strip. The proximal anastomo- 
sis wa, then completed with a running polypropylene sotore 
reinforced with two strips of pericardium (Fig. I, B and C). 
When a homograft conduit with proximal Dacron augmen- 
lation was used. the graft was constructed wilk tke~teck- 
nique described by Bailey et 81. (IS): the Dacron tube is 
scalloped t” accommodate the sinuses of the homograft 
valve root. When a stenosis was present at the pulmonary 
artery bilxcation. a pulmonary homograft hat contained its 
native biforce!i”n was used for reconstruction, augmented 
by pericardium ahcr. necessary. 
Afwr the patient was wnoved from cardiopulmonary 
bypass. the anastom”ses were checked for bleedinr. Throm- 
bi&oaked Gelf”am or cryoprecipi:a:e-tkrombio-glue, or 
both. WBS used :” control sipniticant bleeding from s!itches. 
Right atrial and I& atrial p&ore lines wereplaced. ai well 
es epicardial pacing wires. The chest was closed wth 
attention given to positioning of the conduit o :.void sternal 
compression. A piece of Marler oi i&c:“” mesh or, more 
recently, Gore-Tex memb,.“e. was placed iaderwdth the 
sterwm to protect !he conduit should reoperatioo be “eces- 
wy. lo seven patients sternnl closure was not tolerated and 
the chest was left open during the early postoperative 
period. 
Follow-up. Early mortakty included all deaths occurring 
within 30 days of operation, as well as all hospitsl deaths. 
Long-term follow-u; was obtained from r&w of clinic 
records, conversation with the referring pedistnc cardiolo- 
gist and direct c”“tact with the patient and family. Available 
postoperative echocardiographic or catheterization data 
were obtained. and all patients were assigned a New York 
Heart Association Cuunctional class. 
Results 
Early outcome (Table I). The early mtirtality rate was 
8.8% overall t I3 of 148). It was 22% (8 of 37) in patients with 
a Dacron conduit compared with only 3.8% (4 of 106) in 
those with a homograft. A” additional early death occurred 
in the one patient who received a nonvalved Gore-Tex 
conduit. The early mortality rate in the later years of the 
study (from 1985 to June 1991) was only 3.4% (3 of 117). The 
early mortality rate was relatively higher for patients under- 
going conduit placement for both tr”nc”s arteriosus (16.7%) 
and pulmonary atresia with ventricular septal defect (12%): 
it was low (3.9%) in the group with complex transposition of 
the great arteries. There were two intraoperative deaths. 
Two deaths were secondary t” tamponade: one presumably 
from bleeding from stitches in a Dacron conduit and the 
other from sudden conduit bleeding in a hom”graft recipient 
with suprasystemic right ventricular pressure. Two deaths 
occurred secondary to respiratory failure and we” deaths 
secondary t” primary myocardial failure with subsequent 
multisystem failure. An additional patient with complex 
transposition of the great arteries underwent successful 
orlhotoplc heart transplantation pelformed 4 days postoper- 
atively because of mvocardial failure. 
One early death occurred in a 14.month “Id boy with 
tetralogy of Fallot who underwent attempted tetrology repair 
but was unable I” undergo right ventricular outflow tract 
patckiog because of a coronary artery anomaly. He was 
returned to the operating r”“m for placement of a 16.mm 
porcine-valved Dacron conduit the following day and died 
postoperatively from myocardial failure despite support with 
an intraaortic balloon pump. A second early death occurred 
Figure 1. Repair of trmm siteriosus type I with a sryoprrwued homograft. A. A 
ventriculalamy 1s made in the right ventricular outflow ~mcr. 8. .The venmcuiar 
seplal dsfect WSD) is closed elther pnmarily or with a double-velour Dacron pxch 
The pulmonary ancry is detached from the tnmw and the aoruc defecr clowd eNher 
primarily or more cendy wth a glutaraldehydc-[reared p ricardial patch. C. The 
distal anasromoeis. reinforced with a strip of pericardrum. 15 completed firsl. The 
hamografl is augmented proxiroally with Dawn a4 the ~enm~ular ~na~tornu~~~ is 
reinforced with a pericardial strip. 
in an I I-day old infant with Iruncuh aneriosus type II nnd 
interrupted sonic arch who underwent repair with placc- 
Me outcome (Table 2). Long-lerm foilow-up of 135 
par~eors (average 57 months, range 2 to 177 mwthr) showed 
ment of a 13.mm homograft. The infant was critically ill 
preoperalively and had a cardiopulmonary arrest in the 
a late mortality rate of only 3%. The late mortality rate was 
operating room before operation. He was resuscitated and 
7.1% in the group with a Dacron porcine-valued conduit. 
underwent homograit placement: he died 2 days postopera- 
One late death in this group occurred on postoperative day I 
tively fmm primary mycardial failure. One death occurred 
after repeat operation in a patient with pulmonary atresia 
in a 2.month old patient with truncus arteriosus type I who 
and ventricular septal defect who required replaceman of a 
underwent placement of a 12.mm homograft and died on 
Dacron conduit I I months postoperalively secondary to 
critkal conduit stenosis. Eight of the 28 Dacron conduit 
postoperative day I from rapiratory amxt secondary to 
dislcdgment of the endotracheal tube (Table I). 
recipients followed up required conduit replacement for 
absrructun during a mean follow-up interval of 7R months 
PA.VSD 
PA.YSD 
PA-W” 
(28.6% replacement rate at 93 months). The earliest replace- 
ment of a Dacron. conduit occurred I I months pos~opera- 
tivety. Current evaluation of the remaining Dacron conduits 
reveals progressive peel formation in seven and valvular 
stenosis and degeneration with signilicant regurgitation in 
five, with the incidence more prevalent in the older conduits. 
One of the two patients with a nonvalved Dacron conduit 
required piacemem of a porcine valve 9 m~lhs poslopera- 
lively because of valve regurgitation. Both of these Wio 
patirn:s are currently doins well. 
The homoeraft conduit erour, had a late mortalitv rate of 
1.9%. In lOt&ents follo&d’up B mean of 50 mdnths six 
homografts required replacement brcause of obstruction. A 
localized fibrous stenosis that was probably technical in 
nature developed in one homograft. The lesion was success- 
fully dilated by balloon angioplasty on two separate occa- 
EIOIIS with good functional results; the first dilation reduced 
a 50.mm Hg gradient to 20 mm Hg. and the second reduced 
a 40.mm Hg gradient to 20 mm Hg. One late death occurred 
secondary to right ventricular failure in a hamograft recipi- 
ent 6 months after repair oftetralogy of Fallot. A second late 
death occurred secondary to left ventricular failure 5 months 
postoperatively in a patient with truncus arteriosur. 
On follow-up, the majority of homograft conduits had 
calcification of the conduit wall. bul relatively few mani- 
fated valve lea&t calcification. Available catheterization 
and echocardiographic data revealed five nild gradients of 
10 to 22 mm Hg in five patients. all with complcn transposi- 
tion of the great arteries. The she of stenosis in the ho- 
mografts was usually in the distal portion of the conduit. 
Discussion 
Early outcome. Before the development d an adequate 
replacement conduit. complex cardiac lesions requiring cle- 
ation of a connection between the right ventricle and pulmo- 
nary artery could not be corrected. The introduction of the 
valved conduit has greatly facilitated the surgical repair of 
these various lesions whose basic defect is right ventricular 
to pulmonary artery discontinuity (conotruttcal abnormali- 
ties) (l-3). The operative mortality rate has gradually de- 
creased with improvement in myocardial protection, sur&rd 
technique and conduit design and availability. The early 
monatity rate in our series (8.8%) comparer quite favorably 
with that of other wien (IO% to 35%) (9-12,16.17,t9). 
In our more recent experience utilizing the cryopreserved 
homoeraft. the earlv monalitv rate deceased to 3.8% (4 of 
106), kdicating an~apparent .benefd with respect to early 
mortality with use of tbe cryopreserved homograft (3.8%) 
rather than the Dacron porcine-valved conduit (22%). The 
early mortality rate nith-the Dacron porcine-valved conduit 
is comparable to that mooned by the group (16) at Boston 
Child&n’s Hospital t?Z%). Although the cryopreserved ho- 
monraft was used later in our experience than the Dacron 
por&e-valved conduit. our impression is that the superior 
hemosmlic properties, ease of insertion and decreased risk 
of early obslruction of the homograft arc also responsible for 
these improved resuhs. 
Early monolity was relatively higher for patients under- 
going conduit placement for truncus arteriosus or pulmonary 
atresia with ventricular septal defect than for other patient 
groups. This Endmg is simila; to tba: of rxany oifirr Series 
and in the case of trunws arlcriosus may be due to the younp 
age and poor preoperative ,tatu~ of the pacot*. a\ cam- 
plificd by the I- and 2-month old paoentr wrh !iu,,cos 
arteriosus and in[errupted aorlic arch m our WC-, 
Of interest is the low operative mortabry’3.‘Y?! in :>c 
group with complex transposition of the great arteries m our 
series. Reports from other surgical umts I I .6.18-20) mdlcate 
difficulty with conduit placement and stcrnill comp:~~mn m 
this group. which has resulted in a higher early mortabty and 
a higher incidence of early conduit stenos~. In parents unh 
transposition and left ventricular outflow tr*ict obctruaion 
there is B tendency to place the condolt !o the right of 
the aorta because the pulmonary artery ic more xcessible 
on that side. This may resull m condud compression and 
low cardiac output contributing to the increased early 
mortality. Improper positioning rwlts :!I turbulence that 
accelerates pseudoinrimal peel formation (t3.21). In rhe 
series of Bailey et al. (18). compression of the conduit 
between the sternum and the heart was the primary cause 
of early obstruction. Both strict attention to conduit 
placement and leaving the sternum open in the early port- 
operative period when necessary has been helpful m main- 
taining p low early mortality rate in complex transposition. 
Marc recent experience (17.19) with rhe cryoprescrvcd 
homograft has been associated vitb a lower incidence of 
early conduit obstruction in complex transposition of the 
great arteries. 
Surgical timing. The tmtmg of definttive surgical repair IS 
an important aspect of the treatment of conotruncal abnor- 
malities. Early corrective repair is advocated by many to 
prevent the development of pulmonary hypertension sec- 
ondary to i long-standing shunt or torrential pulmonary 
blood Row with a pulmonary to systemic flow ratio lQp/Qs) 
>3:l. Prior palliative shunts and pulmonary hypertension 
have been dkectly related to increased operative motiality in 
patients undergoing conduit placement (16). Many advocate 
that corrective repair should be undertaken as early as 6 to 
I2 months after the placement of a shunt, whereas others 
(IO) have suggested avoiding palliative shunts altogether and 
undertaking total correction when severe hypoxia or conges- 
tive failure occur but before the development of pulmonary 
hypertension. We propose a slaged approach. A palliative 
shunt of correct size should be placed initially for those 
patients with inadequate pulmonary blood flw. In most 
cases, definitive repatr shuuld be undertaken at age 4 to 5 
wars before the child starts school. Bv this aae the oatient 
bar gained sufficient size to allow UFC bf a ge&wsl~ sized 
conduit that will not be rapidly outgrow. Performing the 
operation before the child starts school avoids interruption 
of the child’s social development and education. Patients 
should be followed up closely after a palliative shunt and 
definitive repair should be undenaken earlier if signs of 
pulmonary hypertension. ventriculm rdilurc or worsening 
cyanosis occur. 
This staged approach is appropriate for children with 
.omplc,> imn\po~tmo. childrev with pulmonary atreG with 
vcntnc~i.~r wp!al defect and some patients with complex 
form\ of terralogy of Fallot However. in paen& with 
trunco~ ilr~cr~ow~ definitive repair should be undcrt :ken in 
~nRncy. prehmmary pulmonary artery banding is rarely 
~nds:ircd (22,. 
Late outcome. The long-term outcome of patients under- 
gomg nghl ventricle to pulmonary artery conduit placement 
has ,readlly rmproved and 1s much more favorable than the 
~oaturai hwory of these anomalies. Patients surviving soigi- 
cal repar tend lo have excellent clinical results, dependent 
mactly on then ventricular function. However. the long-term 
patency of the conduit is finite. resulting eventually in the 
need for condud replacement in the majority of patients. 
Allhough conduit replacement is generally well tolerated. 
the associated nsk is equal to that of any mediastinal 
reoperatwn. with the added danger of injury to the conduit 
on making the sterootomy. In addition to a 7% operative 
mortality rate reported for reaperations, Schatl et al. (231 
reported a I?% to 27% incidence rate of serious hemorrhage 
during a?rnai reemry. In our experience only one early 
death (4 861 occurred in 21 reoperations for right ventricular 
to pulmonary artcry conduit replacemen?. Carefu: preoper- 
ative evaluation including lateral chest radicgnphy and the 
use of the osciliating saw are useful in avoiding injury to the 
conduu a! moper&ion 124). 
A valve i% neceswv in most rieht ventricular to oulmo- 
nary arlery conduits baause e&&d right-sided p&ore 
results in pulmonary regurgitation and right heart failure 
when a nonvalved conduit is used. Bioprosthetic vatred 
conduitr tend to ca!cify and devc!op pseudointimal peel 
formation resulting in stenosis and eventual valve and con- 
duit failure. In the Boston Children’s Hosital exwrience 
ll I.161 with the Ds:ron porcioe-valved cbnduits.. the re- 
placement rale of valved conddt was 1% at 5 years. 3% at 
7 yean and 100% at IO years. Our own data similarly 
demonstmte a 25% replacement rate at a mcao follow-up 
interval of 7.5 years. 
Our rcsal,~ ssgg~r imprvwd vnlw and conduit longeviry 
with rhe nypreserwd homogroft. which retains viable 
fibroblws and endothelial cells. allowing for continxd 
productnon ot collagen and repair of the KIIX matrix and 
intima (25-28). Homografts have a more favorable patency 
profile and are easier to implant than is the standard 
Dacron porcine-valved conduit. A cryopreservcd homograft 
valve lifespan of 22 years has been obtained in the sonic 
position 129) and a lifespan >I5 to 20 years should be 
possible for homograft conduits. The homograft is probably 
the moct suitable extracardiac conduit in terms of its ease of 
handling. natural hemostatic properties and long-term dura- 
bibty and patency. However, availability ccntinuer to be a 
problem. 
ConctuGos. The imraductiao of the valved conduit has 
greatly faciiitated the surgical repair of many congenital 
cardiac lesions that were previously uncorrectable and ame- 
nable only to palliative repair. The overall mortality rate for 
thcsc defects has decreased markedly ~mce the introduction 
of the vaived condw. The cryopreserved homografi is 
technically easier to USC and hence is able to he placed in a 
more favorable position, avoiding sternal compression and 
kinking. Avoidance of bleeding from stitches with the ho- 
mografr may result in B decreased incidence of postoperative 
hlocdiog nod txxponadc. The irrporlance of continued cell 
viability for conduit and valve langcviiy makes the ho- 
mografl, with current methods of cryopreservation, the 
preferred right venlricle to pulmonary atiery conduit. Re- 
duced early mortality and improved long-term patency and 
fun&m are possible wilh the antibiotic-sterilized. nutrient. 
presewed fresh or fresh-frozen homogmft. 
